Ilia I. Ouspenski

Array ( [id] => 8209029 [patent_doc_number] => 20120128698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DEMYELINATING DISEASES' [patent_app_type] => utility [patent_app_number] => 13/381304 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15078 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128698.pdf [firstpage_image] =>[orig_patent_app_number] => 13381304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024203 [patent_doc_number] => 20110052529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS' [patent_app_type] => utility [patent_app_number] => 12/823430 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25948 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052529.pdf [firstpage_image] =>[orig_patent_app_number] => 12823430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623708 [patent_doc_number] => 20100311162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture' [patent_app_type] => utility [patent_app_number] => 12/819533 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18452 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311162.pdf [firstpage_image] =>[orig_patent_app_number] => 12819533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527382 [patent_doc_number] => 08303952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Methods for inducing in vivo tolerance' [patent_app_type] => utility [patent_app_number] => 12/796392 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9461 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12796392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292533 [patent_doc_number] => 20100239569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Method Of Treating Disorders Of The Cardiovascular System And A Pharmaceutical Agent' [patent_app_type] => utility [patent_app_number] => 12/793902 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26229 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239569.pdf [firstpage_image] =>[orig_patent_app_number] => 12793902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343058 [patent_doc_number] => 20100330034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'USE OF BISPECIFIC ANTIBODIES TO REGULATE IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 12/787044 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12724 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330034.pdf [firstpage_image] =>[orig_patent_app_number] => 12787044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148736 [patent_doc_number] => 20110020331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'N-GLYCOSYLATED ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/786378 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6492 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020331.pdf [firstpage_image] =>[orig_patent_app_number] => 12786378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580279 [patent_doc_number] => 20110294162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'B-7 RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION' [patent_app_type] => utility [patent_app_number] => 12/783968 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 76218 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294162.pdf [firstpage_image] =>[orig_patent_app_number] => 12783968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519299 [patent_doc_number] => 20100203059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT' [patent_app_type] => utility [patent_app_number] => 12/765385 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26178 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203059.pdf [firstpage_image] =>[orig_patent_app_number] => 12765385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953182 [patent_doc_number] => 20110033884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'PD-1, A Receptor for B7-4, and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 12/761704 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 59425 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033884.pdf [firstpage_image] =>[orig_patent_app_number] => 12761704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807549 [patent_doc_number] => 08445200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Genotoxicity as a biomarker for inflammation' [patent_app_type] => utility [patent_app_number] => 12/761330 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 35 [patent_no_of_words] => 17343 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12761330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7752022 [patent_doc_number] => 08110665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-07 [patent_title] => 'Pharmaceutical composition comprising an immunoglobulin FC region as a carrier' [patent_app_type] => utility [patent_app_number] => 12/759801 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19017 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/110/08110665.pdf [firstpage_image] =>[orig_patent_app_number] => 12759801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560039 [patent_doc_number] => 08334102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Human CD28 specific monoclonal antibodies for antigen-nonspecific activation of T-lymphocytes' [patent_app_type] => utility [patent_app_number] => 12/756665 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 5212 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007037 [patent_doc_number] => 20110059068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'POLYPEPTIDES INVOLVED IN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/753819 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 31407 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059068.pdf [firstpage_image] =>[orig_patent_app_number] => 12753819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195524 [patent_doc_number] => 20110027278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'REGULATORY T CELL MEDIATOR PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/732371 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 49265 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027278.pdf [firstpage_image] =>[orig_patent_app_number] => 12732371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783891 [patent_doc_number] => 20120045447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'T CELL COSTIMULATING POLYPEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/732360 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7503 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045447.pdf [firstpage_image] =>[orig_patent_app_number] => 12732360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146540 [patent_doc_number] => 08163546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Mammalian cell-based immunoglobulin display libraries' [patent_app_type] => utility [patent_app_number] => 12/748247 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18209 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163546.pdf [firstpage_image] =>[orig_patent_app_number] => 12748247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257651 [patent_doc_number] => 08207130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Combination cancer immunotherapy with co-stimulatory molecules' [patent_app_type] => utility [patent_app_number] => 12/732147 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18592 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12732147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398405 [patent_doc_number] => 08268788 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Combination cancer immunotherapy with co-stimulatory molecules' [patent_app_type] => utility [patent_app_number] => 12/732140 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18581 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12732140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955401 [patent_doc_number] => 08501171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Use of ADCC-optimized antibodies for treating weak patients' [patent_app_type] => utility [patent_app_number] => 12/659824 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6894 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12659824 [rel_patent_id] =>[rel_patent_doc_number] =>)